AOD-9604
A growth-hormone fragment dedicated to fat breakdown (lipolysis).
iThe essentials in 10 seconds
- Growth hormone fragment dedicated to fat breakdown
- Acts on lipolysis (fat mobilization) without affecting blood glucose
- Does not stimulate GH or appetite — no systemic hormonal effect
- Subcutaneous injection, often on an empty stomach and before exercise
IWhat is AOD-9604?
AOD-9604 is a fragment (177-191) of growth hormone, isolated for its action on fat. It stimulates lipolysis and inhibits fat storage, without increasing blood glucose or GH as the whole hormone would. Studied for obesity, it did not demonstrate the expected weight loss in trials — but remains valued for targeted use.
Clinical trials have not confirmed major weight loss. Modest and variable results: consider it as a supplement, never as a treatment for obesity.
The molecules presented on this site are innovative and fall under experimental use. Human data remain limited: a studied mechanism or a preclinical observation is not sufficient to demonstrate a benefit. The regulatory status in Morocco is not established for most of these peptides. Any use is decided within the framework of a medical consultation, with follow-up — never alone, never without an assessment.
IIThe benefits
Stimulates fat breakdown (lipolysis) by fat cells.
Inhibits fat storage and the formation of new fat cells.
Unlike GH, does not increase blood glucose or insulin resistance.
Does not stimulate appetite (unlike GLP-1 or GH).
Taken on an empty stomach / before exercise, supports fat oxidation during training.
Generally simple tolerance profile (few systemic effects).
IIIRecommendations & how to use
Route: subcutaneous injection (abdomen) · Timing: on an empty stomach, often before exercise (in the morning) · Frequency: daily or 5 days/7 in a cycle · Storage: refrigerated (2–8 °C).
Away from sugary meals; the effect remains modest without a healthy lifestyle.
| Dosage | Price |
|---|---|
| 5 mg | Provided on request |
Prices are not published online: they are provided on request, during a consultation or by telephone.
IVThe two protocols
Goal: support fat mobilization as a complement to diet.
Monitoring: waist circumference, body composition, tolerance.
Goal: support fat utilization during training.
The effect is modest: diet and activity do most of the work.
VProtocol rules
- Inject on an empty stomach, away from sugars
- Regular physical activity (walking, cardio)
- Record waist circumference and composition
- Store vials in the refrigerator
- Look at real results, without expecting miracles
- No self-injection without medical training
- Do not expect weight loss without a healthy lifestyle
- Do not chain cycles without a break
- Never mix peptides in the same vial
- Pregnancy, breastfeeding, active cancer: medical advice
VIYour journey in 3 steps
Evaluation, contraindications, training, protocol provided.
Injections on an empty stomach (in the morning / before exercise), waist circumference monitoring.
Body composition assessment, decision on next steps.
VIISide effects & level of evidence
- Headache
- Nausea
- Injection-site reaction (pain, redness)
- Possible fasting hypoglycaemia: monitor
- Pregnancy, breastfeeding
- History of cancer (growth-hormone fragment)
- Insulin-treated diabetes: monitor glucose
- Hypersensitivity
Non-exhaustive list based on the available literature and known class effects; it replaces neither a product label nor an individual medical assessment.
VIIIPublications & references
- AOD-9604 MetabolicWilding J · Curr Opin Investig Drugs · 2004 · PMID 15134286
- Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future DirectionsRahman et al. · J Am Acad Orthop Surg Glob Res Rev · 2026 · PMID 41490200
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic PerformanceMendias CL, Awan TM · Sports Med · 2026 · PMID 41966639
Documentary references: the existence of a publication establishes neither efficacy nor safety for personal use. The regulatory status in Morocco must be verified.